# An autopsy case of idiopathic fulminant eosinophilic myocarditis: a case report

**Authors:** Eiji Koyama, Masashi Yamaguchi, Hiroshi Koyama, Shinichi Teshima, Shigeru Saito

PMC · DOI: 10.1093/ehjcr/ytaf262 · 2025-05-26

## TL;DR

A 68-year-old woman with severe heart inflammation (eosinophilic myocarditis) was treated with steroids and mechanical support, but she ultimately died despite initial improvement.

## Contribution

This case report highlights the potential benefit of early steroid treatment in fulminant eosinophilic myocarditis, even before biopsy confirmation.

## Key findings

- The patient showed biventricular dysfunction and was treated with mechanical circulatory support and steroids.
- Autopsy revealed minimal inflammatory cell infiltration and extensive myocardial necrosis.
- Steroid treatment improved left ventricular function but not right ventricular function.

## Abstract

Eosinophilic myocarditis is a rare and fatal form of inflammatory myocardial disease. It is frequently caused by a systemic disorder, which can remain undetected in up to one-third of patients. Eosinophilic myocarditis can have mild to fulminant clinical presentation.

We present a case of fulminant eosinophilic myocarditis in a 68-year-old woman. The patient was admitted for cardiogenic shock with electrocardiographic abnormalities and elevated troponin I levels. After an unremarkable coronary angiography, a myocardial biopsy was performed. Right-heart catheterization revealed low cardiac output and elevated mean pulmonary arterial wedge pressure. A lower pulmonary artery pulsatility index (0.63) indicated right ventricular dysfunction. Despite intensive treatment including dobutamine, the patient suffered a cardiac arrest triggered by sustained ventricular tachycardia. The patient was successfully resuscitated using veno-arterial extracorporeal membrane oxygenation and intra-aortic balloon pumping (IABP). IABP was upgraded to Impella CP at our hospital after the patient could not maintain her blood pressure. A biopsy showed eosinophilic myocarditis, despite a stagnant peripheral blood eosinophil count. Initiating methylprednisolone and immunoglobulin therapies improved left ventricular function. However, right ventricular function did not improve. Despite these treatments, the patient died 31 days after admission. Autopsy revealed minimal infiltration of inflammatory cells, suggesting the effectiveness of this medication. However, extensive necrotic changes were observed in the myocardium.

This case involved fulminant eosinophilic myocarditis with biventricular dysfunction treated with mechanical circulatory support and steroid therapy. Prompt steroid treatment before confirmation of biopsy results may improve the prognosis.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), dobutamine (PubChem CID 36811)
- **Diseases:** cardiogenic shock (MONDO:0800175), ventricular tachycardia (MONDO:0005477)

## Full-text entities

- **Diseases:** cardiac arrest (MESH:D006323), inflammatory (MESH:D007249), low cardiac output (MESH:D002303), electrocardiographic abnormalities (MESH:C566733), necrotic (MESH:D009336), cardiogenic shock (MESH:D012770), Eosinophilic myocarditis (MESH:D009205), right ventricular dysfunction (MESH:D018497), biventricular dysfunction (MESH:D018754), ventricular tachycardia (MESH:D017180), myocardial disease (MESH:D004194)
- **Chemicals:** methylprednisolone (MESH:D008775), dobutamine (MESH:D004280), steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12168754/full.md

---
Source: https://tomesphere.com/paper/PMC12168754